BackBioNexus Gene Lab Overview

BioNexus Gene Lab Operating Income

Operating Income for BGLC.

Quarterly Operating Income

$-540490.00
12.6% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-2886292.00
1.52% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)